Regardless whether a large pharmaceutical company, a SME or a start-up – there always are a variety of market access challenges on a national or international level and throughout the product life-cyle, be it pharmaceutical products, (in vitro-) diagnostics or medical devices.
For all or any of these challenges I will apply my expertise to provide support for you to enable patients to benefit from your innovations:
Support for international companies looking to enter the EU market with their innovations, e.g. education on current and future market access processes and regulations, on EU HTA, strategic support to plan & prepare for entering the EU market, etc.
Strategic Consulting in early stages of a product life-cycle, i.e. planning of pivotal studies to enable optimal outcomes according to relevant requirements, as well as for the approach in the market access process.
Support for the market access process as a whole or for specific components, e.g., dossier preparation, written statement, oral hearing, negotiations, obtaining expert advice, etc.
Supporting projects such as market analysis regarding access, internal trainings for your staff, etc.